{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:08:02Z","timestamp":1792681682530,"version":"4.5.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2011,7,19]],"date-time":"2011-07-19T00:00:00Z","timestamp":1311033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In hypoparathyroidism, plasma parathyroid hormone (PTH) levels are inadequate to maintain plasma calcium concentration within the reference range. On conventional treatment with calcium supplements and active vitamin D analogues, bone turnover is abnormally low, and BMD is markedly increased. We aimed to study the effects of PTH-replacement therapy (PTH-RT) on calcium-phosphate homeostasis and BMD. In a double-blind design, we randomized 62 patients with hypoparathyroidism to daily treatment with PTH(1\u201384) 100\u2009\u00b5g or similar placebo for 24 weeks as add-on therapy to conventional treatment. Compared with placebo, patients on PTH(1\u201384) reduced their daily dose of calcium and active vitamin D significantly by 75% and 73%, respectively, without developing hypocalcemia. However, hypercalcemia occurred frequently during the downtitration of calcium and active vitamin D. Plasma phosphate and renal calcium and phosphate excretion did not change. Compared with placebo, PTH(1\u201384) treatment significantly increased plasma levels of bone-specific alkaline phosphatase (+226%\u2009\u00b1\u200936%), osteocalcin (+807%\u2009\u00b1\u2009186%), N-terminal propeptide of procollagen 1 (P1NP; +1315%\u2009\u00b1\u2009330%), cross-linked C-telopeptide of type 1 collagen (CTX; +1209%\u2009\u00b1\u2009459%), and urinary cross-linked N-telopeptide of type 1 collagen (NTX; (+830%\u2009\u00b1\u2009165%), whereas BMD decreased at the hip (\u22121.59%\u2009\u00b1\u20090.57%), lumbar spine (\u22121.76%\u2009\u00b1\u20091.03%), and whole body (\u22121.26%\u2009\u00b1\u20090.49%) but not at the forearm. In conclusion, the need for calcium and active vitamin D is reduced significantly during PTH-RT, whereas plasma calcium and phosphate levels are maintained within the physiologic range. In contrast to the effect of PTH(1\u201384) treatment in patients with osteoporosis, PTH-RT in hypoparathyroidism causes a decrease in BMD. This is most likely due to the marked increased bone turnover. Accordingly, PTH-RT counteracts the state of overmineralized bone and, during long-term treatment, may cause a more physiologic bone metabolism. \u00a9 2011 American Society for Bone and Mineral Research<\/jats:p>","DOI":"10.1002\/jbmr.470","type":"journal-article","created":{"date-parts":[[2011,7,19]],"date-time":"2011-07-19T11:39:58Z","timestamp":1311075598000},"page":"2358-2370","source":"Crossref","is-referenced-by-count":162,"title":["The effect of adding PTH(1\u201384) to conventional treatment of hypoparathyroidism: A randomized, placebo-controlled study"],"prefix":"10.1093","volume":"26","author":[{"given":"Tanja","family":"Sikjaer","sequence":"first","affiliation":[{"name":"Department of Metabolism and Internal Medicine, MEA, THG, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Rejnmark","sequence":"additional","affiliation":[{"name":"Department of Metabolism and Internal Medicine, MEA, THG, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Rolighed","sequence":"additional","affiliation":[{"name":"Department of Surgery P, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene","family":"Heickendorff","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif","family":"Mosekilde","sequence":"additional","affiliation":[{"name":"Department of Metabolism and Internal Medicine, MEA, THG, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Hypoparathyroid Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,7,19]]},"reference":[{"key":"2024020317570644600_bib1","first-page":"175","author":"Ajibade","year":"2010","edition":"2nd ed"},{"key":"2024020317570644600_bib2","first-page":"779","author":"Bilezikian","year":"2001"},{"key":"2024020317570644600_bib3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1056\/NEJMcp0803050","article-title":"Clinical practice. Hypoparathyroidism","volume":"359","author":"Shoback","year":"2008","journal-title":"N Engl J Med."},{"key":"2024020317570644600_bib4","first-page":"791","author":"Bilezikian","year":"2001","edition":"2nd ed"},{"key":"2024020317570644600_bib5","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1210\/jc.2008-1216","article-title":"Hypoparathyroidism: is it time for replacement therapy","volume":"93","author":"Horwitz","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020317570644600_bib6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/eje.0.1460215","article-title":"Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D","volume":"146","author":"Arlt","year":"2002","journal-title":"Eur J Endocrinol."},{"key":"2024020317570644600_bib7","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0033-3182(99)71186-2","article-title":"Psychiatric aspects of parathyroid disease","volume":"40","author":"Velasco","year":"1999","journal-title":"Psychosomatics."},{"key":"2024020317570644600_bib8","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.1996.03540080053029","article-title":"Synthetic human parathyroid hormone 1\u201334 vs calcitriol and calcium in the treatment of hypoparathyroidism","volume":"276","author":"Winer","year":"1996","journal-title":"JAMA."},{"key":"2024020317570644600_bib9","first-page":"3480","article-title":"A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1\u201334 in treatment of hypoparathyroidism","volume":"83","author":"Winer","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020317570644600_bib10","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1210\/jc.2002-021736","article-title":"Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1\u201334) versus calcitriol and calcium","volume":"88","author":"Winer","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020317570644600_bib11","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1210\/jc.2007-2552","article-title":"Effects of once versus twice-daily parathyroid hormone 1\u201334 therapy in children with hypoparathyroidism","volume":"93","author":"Winer","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020317570644600_bib12","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1210\/jc.2009-2464","article-title":"Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1\u201334 versus calcitriol and calcium","volume":"95","author":"Winer","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020317570644600_bib13","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00198-009-1149-x","article-title":"Therapy of hypoparathyroidism with intact parathyroid hormone","volume":"21","author":"Rubin","year":"2010","journal-title":"Osteoporos Int."},{"key":"2024020317570644600_bib14","first-page":"82","author":"Hermann"},{"key":"2024020317570644600_bib15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/8756-3282(94)00054-9","article-title":"Cross calibration of QDR-2000 and QDR-1000 dual-energy X-ray densitometers for bone mineral and soft-tissue measurements","volume":"16","author":"Abrahamsen","year":"1995","journal-title":"Bone."},{"key":"2024020317570644600_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0378-5122(00)00158-4","article-title":"Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women \u2013 results of the Danish Osteoporosis Prevention Study","volume":"36","author":"Mosekilde","year":"2000","journal-title":"Maturitas."},{"key":"2024020317570644600_bib17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.0954-6820.1970.tb08076.x","article-title":"Tubular reabsorption of calcium in the differential diagnosis of hypercalcaemia. Further experience","volume":"188","author":"Transbol","year":"1970","journal-title":"Acta Med Scand."},{"key":"2024020317570644600_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0009-8981(69)90280-0","article-title":"The assessment of phosphate reabsorption","volume":"26","author":"Bijvoet","year":"1969","journal-title":"Clinica Chimica Acta."},{"key":"2024020317570644600_bib19","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1373\/clinchem.2005.052936","article-title":"Routine Isotope-Dilution Liquid Chromatography-Tandem Mass Spectrometry Assay for Simultaneous Measurement of the 25-Hydroxy Metabolites of Vitamins D2 and D3","volume":"51","author":"Maunsell","year":"2005","journal-title":"Clin Chem."},{"key":"2024020317570644600_bib20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.cca.2009.10.010","article-title":"High-throughput liquid-liquid extraction and LCMSMS assay for determination of circulating 25(OH) vitamin D3 and D2 in the routine clinical laboratory","volume":"411","author":"Hojskov","year":"2010","journal-title":"Clinica Chimica Acta."},{"key":"2024020317570644600_bib21","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/clinchem\/41.10.1439","article-title":"Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies","volume":"41","author":"Rosenquist","year":"1995","journal-title":"Clin Chem."},{"key":"2024020317570644600_bib22","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/jbmr.5650071119","article-title":"A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine","volume":"7","author":"Hanson","year":"1992","journal-title":"J Bone Miner Res."},{"key":"2024020317570644600_bib23","doi-asserted-by":"crossref","first-page":"E915","DOI":"10.1152\/ajpendo.00315.2009","article-title":"The calcium-sensing receptor (CaSR) defends against hypercalcemia independently of its regulation of parathyroid hormone secretion","volume":"297","author":"Kantham","year":"2009","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"2024020317570644600_bib24","doi-asserted-by":"crossref","first-page":"F485","DOI":"10.1152\/ajprenal.00608.2009","article-title":"Physiology and pathophysiology of the calcium-sensing receptor in the kidney","volume":"298","author":"Riccardi","year":"2010","journal-title":"Am J Physiol Renal Physiol."},{"key":"2024020317570644600_bib25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00467-009-1260-4","article-title":"Overview of the FGF23-Klotho axis","volume":"25","author":"Kuro-o","year":"2010","journal-title":"Pediatr Nephrol."},{"issue":"121","key":"2024020317570644600_bib26","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1038\/ki.2011.27","article-title":"Phosphate and FGF-23","author":"Juppner","year":"2011","journal-title":"Kidney Int."},{"key":"2024020317570644600_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev.med.051308.111339","article-title":"Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23","volume":"61","author":"Bergwitz","year":"2010","journal-title":"Annu Rev Med."},{"key":"2024020317570644600_bib28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1210\/endo-110-1-294","article-title":"Parathyroid hormone stimulates mammalian renal 25-Hydroxyvitamin D3-1{alpha}-hydroxylase in vitro","volume":"110","year":"1982","journal-title":"Endocrinology."},{"key":"2024020317570644600_bib29","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1210\/endo.140.5.6691","article-title":"Positive and Negative Regulations of the Renal 25-Hydroxyvitamin D3 1\u03b1-Hydroxylase Gene by Parathyroid Hormone, Calcitonin, and 1{alpha},25(OH)2D3 in Intact Animals","volume":"140","author":"Murayama","year":"1999","journal-title":"Endocrinology."},{"key":"2024020317570644600_bib30","first-page":"209","article-title":"Increased catabolism of 25-hydroxyvitamin D in patients with partial gastrectomy and elevated 1,25-dihydroxyvitamin D levels. Implications for metabolic bone disease","volume":"82","author":"Davies","year":"1997","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020317570644600_bib31","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1210\/jc.2009-2682","article-title":"Parathyroid hormone stimulates circulating osteogenic cells in hypoparathyroidism","volume":"96","author":"Rubin","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020317570644600_bib32","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/0026-0495(76)90133-5","article-title":"The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part III of IV parts; PTH and osteoblasts, the relationship between bone turnover and bone loss, and the state of the bones in primary hyperparathyroidism","volume":"25","author":"Parfitt","year":"1976","journal-title":"Metabolism."},{"key":"2024020317570644600_bib33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11914-008-0005-9","article-title":"Combination anabolic and antiresorptive therapy for osteoporosis: opening the anabolic window","volume":"6","author":"Bilezikian","year":"2008","journal-title":"Curr Osteoporos Rep."},{"key":"2024020317570644600_bib34","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1056\/NEJMoa071408","article-title":"Teriparatide or alendronate in glucocorticoid-induced osteoporosis","volume":"357","author":"Saag","year":"2007","journal-title":"N Engl J Med."},{"key":"2024020317570644600_bib35","doi-asserted-by":"crossref","first-page":"326","DOI":"10.7326\/0003-4819-146-5-200703060-00005","article-title":"Effect of recombinant human parathyroid hormone (1\u201384) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial","volume":"146","author":"Greenspan","year":"2007","journal-title":"Ann Intern Med."},{"key":"2024020317570644600_bib36","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1359\/jbmr.080803","article-title":"Dynamic and structural properties of the skeleton in hypoparathyroidism","volume":"23","author":"Rubin","year":"2008","journal-title":"J Bone Miner Res."},{"key":"2024020317570644600_bib37","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1210\/jc.2002-021388","article-title":"Increased bone mineral density in patients with chronic hypoparathyroidism","volume":"88","author":"Chan","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020317570644600_bib38","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/8756-3282(95)00443-2","article-title":"Bone histomorphometry in hypoparathyroid patients treated with vitamin D","volume":"18","author":"Langdahl","year":"1996","journal-title":"Bone."},{"key":"2024020317570644600_bib39"},{"key":"2024020317570644600_bib40"},{"key":"2024020317570644600_bib41","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2174\/092986708783330601","article-title":"Recent updates on the calcium-sensing receptor as a drug target","volume":"15","author":"Trivedi","year":"2008","journal-title":"Curr Med Chem."},{"key":"2024020317570644600_bib42","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bone.2009.07.082","article-title":"The calcium-sensing receptor in bone cells: a potential therapeutic target in osteoporosis","volume":"46","author":"Marie","year":"2010","journal-title":"Bone."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.470","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/26\/10\/2358\/56558406\/470_ftp.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/26\/10\/2358\/56558406\/470_ftp.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T10:46:11Z","timestamp":1710326771000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/26\/10\/2358-2370\/7598021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,19]]},"references-count":42,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2011,7,19]]},"published-print":{"date-parts":[[2011,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.470","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,10,1]]},"published":{"date-parts":[[2011,7,19]]}}}